Skip to main content

Month: May 2024

AGS Enters Into Definitive Agreement To Be Acquired By Brightstar Capital Partners for Approximately $1.1 Billion

LAS VEGAS and NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) — PlayAGS, Incorporated (NYSE: AGS) (“AGS” or the “Company”), a global gaming supplier of high-performing slot, table, and interactive products, today announced that it has signed a definitive agreement to be acquired by affiliates of Brightstar Capital Partners (“Brightstar”), a middle market private equity firm focused on investing in industrial, manufacturing, and services businesses.    The Company’s Board of Directors has unanimously approved, and recommended that the Company’s stockholders approve, the agreement. AGS shareholders will receive $12.50 per share in cash. The per share purchase price represents a 41% premium to the Company’s volume-weighted average share price over the last 90 days and a 40% premium to AGS’ closing price on May 8, 2024. AGS is a global...

Continue reading

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting

In preclinical models of cornea endothelial dystrophies, a Surrozen antibody-based Wnt mimetic reduced corneal edema and stimulated endothelial cell proliferation in the cornea Surrozen’s antibody based Wnt mimetic also increased detectable tear volume production in dry eye disease modelsSOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, announced today that preclinical data highlighting the potential for Surrozen’s antibody-based Wnt mimetic technologies to treat cornea endothelial damage and Dry Eye Disease (DED) were presented on May 7, 2024 at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Seattle. “We...

Continue reading

Acadia Energy Announces JDA to Develop 200 MW of Microgrids in New York State

AUBURN, N.Y., May 09, 2024 (GLOBE NEWSWIRE) — Acadia Energy Corporation (OTC: AECX) (“Acadia”), a Smart Energy Integration company, announced today that it has completed a Joint Development Agreement (JDA) with Alternus Clean Energy (NASDAQ: ALCE) (“Alternus”) to co-develop 200 Megawatts (MW) of microgrids in upstate New York. The partnership brings together Alternus’ deep expertise in renewable energy development with Acadia’s unique business model and pipeline of projects in the region. Acadia has created an innovative energy deployment model for the creation of microgrids. This new model creates localized, beneficial partnerships, with municipal entities, for the deployment of the microgrids as Sustainability Hubs. The Sustainability Hub acts as an economic development engine for local community’s to attract new businesses by...

Continue reading

AgriFORCE Delivers Second-Generation RCS Units for Introduction Into Mexican Market

VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) — AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (IP) focused AgTech company, completed delivery of its first batch of eight second-generation AgriForce RCS-Hydroxyl devices, known as the “QuadPro,” to be introduced into the Mexican market, as arranged by its Mexico distributor, Distributor Commercializadora DESICO, a leading distributor of Greenhouse heating, and air ventilation systems in Mexico. The QuadPro offers multiple advantages to the previous generation device, including:No-weld construction Increase in airflow by nearly 200% Reduction in noise level by 40%, making the QuadPro equivalent to a common household refrigerator in terms of decibel level Lighter weight with improved center of gravity design to facilitate...

Continue reading

C-Bond Systems’ Patriot Glass Solutions Dealer Network Grows to 50 Dealers

The Company is currently bidding on projects across the country as the demand for security film and bullet-resistant window film increases SAN ANTONIO, May 09, 2024 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, today announced its Patriot Glass Solutions subsidiary dealer network has grown to include 50 dealers around the U.S. and overseas. “The level of bidding activity is higher than ever, both directly within Patriot Glass Solutions and what we are seeing from our dealers,” said Michael Wanke, President of Patriot Glass Solutions. “We currently are bidding projects in New York, New Jersey, Washington, Montana, Michigan, Colorado, California, St. Lucia, Delaware, Arkansas, Hawaii, Ohio, Florida, and of course Texas. There...

Continue reading

Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update

— Recruitment of the commercial team for our infertility portfolio and the pivotal trial of FemBloc® for permanent non-surgical birth control continues — ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible and innovative therapeutic and diagnostic products, announces financial results for the quarter ended March 31, 2024 and provides a corporate update. Corporate Highlights from 1Q 2024 to dateCompany announced positive topline data from pivotal trial for FDA-cleared FemaSeed® for the treatment of infertility. Company announced the first in-office commercial procedure with FDA-cleared FemaSeed infertility solution at a former investigative site. Appointed Richard...

Continue reading

Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with Chronic Hypoparathyroidism to Be Presented at ECE 2024

COPENHAGEN, Denmark, May 09, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that new TransCon PTH (palopegteriparatide) data supporting clinical and quality-of-life benefits in adult patients with chronic hypoparathyroidism will be presented at the European Congress of Endocrinology being held May 11-14, 2024, in Stockholm. Topics include an oral presentation of new 2-year results from a post-hoc analysis of the Phase 3 PaTHway Trial demonstrating sustained improvements in kidney function in adults with chronic hypoparathyroidism treated with TransCon PTH, as well as a symposium presentation on health and quality-of-life improvements in patients switching from rhPTH(1-84) to TransCon PTH as part of a compassionate use program. “We are pleased to partner with leading experts in endocrinology to present...

Continue reading

Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats

First veterinary commercial sale of the SRT-100 outside the U.S. BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the sale of an SRT-100 system to Chavat Da’at, the Veterinary Specialist Referral Center Knowledge Farm at Beit Verl College in Tel Aviv, to provide a gentler radiotherapy option to treat tumors in dogs and cats. This is the first commercial sale of the SRT-100 for veterinary use outside the U.S. Veterinary Specialist Referral Center Knowledge Farm was established in 2007 at Beit Berl College to provide imaging (ultrasound, CT and radiographs), general orthopedic soft tissue services and veterinary...

Continue reading

Safe & Green Holdings Receives Expanded Scope of Work for Contract with Government Contractor to Refurbish 15 Container Modules for a Major U.S. Agency

Refurbished Container ModulesRefurbished Container ModulesRefurbished Container Modules MIAMI, May 09, 2024 (GLOBE NEWSWIRE) — Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, today announced it has received an expanded scope of work from a government contractor for a previously announced contract to refurbish 15 container modules to be used by a major U.S. government agency. Paul Galvin, Chairperson and CEO of Safe and Green Holdings stated, “We are always honored to work on behalf of our great military, directly and through other contractors. I am delighted to report that a key government contractor has broadened our previously announced engagement to refurbish 15 modular units with additional technological...

Continue reading

Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights

First quarter revenue of $13.2M, +27% year-over-year growth; IFRS gross margin of 75.2% First quarter pulse recurring revenue of $4.7M, +118% year-over-year growth    IFRS and non-IFRS operating loss narrowed to -$1.0M and -$0.4M, respectively; company approaching breakevenSAN CLEMENTE, Calif., May 09, 2024 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the first quarter of fiscal year 2024, for the period ended March 31, 2024, and recent business highlights. First Quarter Fiscal 2024 Financial HighlightsFirst Quarter Revenue of $13.2M; representing 27% year-over-year growthRecurring Revenue of $4.7M, a year-over- year increase of 118%, representing 36% of total revenue Gross Profit...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.